The results support the hypothesis that activating the mTOR pathway can potentiate Aβ and tau pathologies in postnatal slices, suggesting the involvement of mTOR in Aβ and tau-induced AD neurodegeneration. This evidence concerns the gene MAPT and Alzheimer disease.